LAWRENCE COREY
Osteopathic Medicine at Broadway, Seattle, WA
License number
Washington MD00014698
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
600 Broadway SUITE 400, Seattle, WA 98122
Phone
(206) 720-4340
(206) 543-6420
(206) 543-6420
Personal information
See more information about LAWRENCE COREY at radaris.comName
Address
Phone
8033 SE 45Th St, Mercer Island, WA 98040
7805 Island Crest Way, Mercer Island, WA 98040
8033 45Th St, Mercer Island, WA 98040
8033 SE 45Th St, Mercer Island, WA 98040
Professional information
See more information about LAWRENCE COREY at trustoria.com
Lawrence Corey, Seattle WA
Lawrence Corey, Seattle WA
Specialties:
Internal Medicine, Infectious Disease, Clinical Pathology/Laboratory Medicine
Work:
Seattle Cancer Alliance Outpatient Ambulatory
825 Eastlake Ave E, Seattle, WA 98109 University of Washington Medical Center
1959 Ne Pacific St, Seattle, WA 98195
825 Eastlake Ave E, Seattle, WA 98109 University of Washington Medical Center
1959 Ne Pacific St, Seattle, WA 98195
Education:
University of Michigan Medical School (1971)
Lawrence L Corey, Seattle WA
Lawrence L Corey, Seattle WA
Specialties:
Internist
Address:
1100 Fairview Ave N, Seattle, WA 98109
600 Broadway, Seattle, WA 98122
600 Broadway, Seattle, WA 98122
Education:
University of Michigan, Medical School - Doctor of Medicine
University of Washington Medical Center - Fellowship - Infectious Disease (Internal Medicine)
University of Washington Medical Center - Fellowship - Infectious Disease (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Dr. Lawrence Corey, Seattle WA - MD (Doctor of Medicine)
Dr. Lawrence Corey, Seattle WA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
Fred Hutchinson Cncr Rsrch Ctr
1100 Fairview Ave N SUITE D3-100, Seattle 98109
(206) 667-5000 (Phone)
1100 Fairview Ave N SUITE D3-100, Seattle 98109
(206) 667-5000 (Phone)
Certifications:
Internal Medicine, 1974
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Fred Hutchinson Cncr Rsrch Ctr
1100 Fairview Ave N SUITE D3-100, Seattle 98109
Harborview Medical Center
325 9Th Ave, Seattle 98104
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
1100 Fairview Ave N SUITE D3-100, Seattle 98109
Harborview Medical Center
325 9Th Ave, Seattle 98104
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
University of Mi Med Sch
Graduated: 1971
University Of Michigan Hospitals
University Of Washington Medical Center
University of Mi Med Sch
Graduated: 1971
University Of Michigan Hospitals
University Of Washington Medical Center
Immunological Herpes Simplex Virus Antigens And Methods For Use Thereof
Immunological Herpes Simplex Virus Antigens And Methods For Use Thereof
US Patent:
6375952, Apr 23, 2002
Filed:
Aug 5, 1999
Appl. No.:
09/368770
Inventors:
David M. Koelle - Seattle WA
Lawrence Corey - Seattle WA
Lawrence Corey - Seattle WA
Assignee:
University of Washington - Seattle WA
International Classification:
A61K 39245
US Classification:
4241861, 4241921, 4241991, 4242311, 536 234, 536 237, 530350, 435 693, 435 697, 4352351, 4352523, 4353201, 435325
Abstract:
The invention provides HSV antigens that are useful for the prevention and treatment of HSV infection. Disclosed herein are antigens and/or their constituent epitopes confirmed to be recognized by T-cells derived from herpetic lesions or from uterine cervix. T-cells having specificity for antigens of the invention have demonstrated cytotoxic activity against cells loaded with virally-encoded peptide epitopes, and in many cases, against cells infected with HSV. The identification of immunogenic antigens responsible for T-cell specificity provides improved anti-viral therapeutic and prophylactic strategies. Compositions containing antigens or polynucleotides encoding antigens of the invention provide effectively targeted vaccines for prevention and treatment of HSV infection.
Immunological Herpes Simplex Virus Antigens And Methods For Use Thereof
Immunological Herpes Simplex Virus Antigens And Methods For Use Thereof
US Patent:
7744903, Jun 29, 2010
Filed:
Feb 10, 2005
Appl. No.:
11/055477
Inventors:
David M. Koelle - Seattle WA, US
Lawrence Corey - Seattle WA, US
Lawrence Corey - Seattle WA, US
Assignee:
University of Washington - Seattle WA
International Classification:
A61K 39/245
US Classification:
4242291, 435 5
Abstract:
The invention provides HSV antigens that are useful for the prevention and treatment of HSV infection. Disclosed herein are antigens and/or their constituent epitopes confirmed to be recognized by T-cells derived from herpetic lesions or from uterine cervix. T-cells having specificity for antigens of the invention have demonstrated cytotoxic activity against cells loaded with virally-encoded peptide epitopes, and in many cases, against cells infected with HSV. The identification of immunogenic antigens responsible for T-cell specificity provides improved anti-viral therapeutic and prophylactic strategies. Compositions containing antigens or polynucleotides encoding antigens of the invention provide effectively targeted vaccines for prevention and treatment of HSV infection.
Immunological Herpes Simplex Virus Antigens And Methods For Use Thereof
Immunological Herpes Simplex Virus Antigens And Methods For Use Thereof
US Patent:
6855317, Feb 15, 2005
Filed:
Feb 11, 2002
Appl. No.:
10/073834
Inventors:
David M. Koelle - Seattle WA, US
Lawrence Corey - Seattle WA, US
Lawrence Corey - Seattle WA, US
Assignee:
University of Washington - Seattle WA
International Classification:
C12N007/01, C12N015/34, C12N015/86, C12N005/10
US Classification:
4241861, 4241921, 4241991, 4242311, 514 44, 536 2372, 536 234, 4353201, 4352351, 435325, 435375, 435 691, 435 693
Abstract:
The invention provides HSV antigens that are useful for the prevention and treatment of HSV infection. Disclosed herein are antigens and/or their constituent epitopes confirmed to be recognized by T-cells derived from herpetic lesions or from uterine cervix. T-cells having specificity for antigens of the invention have demonstrated cytotoxic activity against cells loaded with virally-encoded peptide epitopes, and in many cases, against cells infected with HSV. The identification of immunogenic antigens responsible for T-cell specificity provides improved anti-viral therapeutic and prophylactic strategies. Compositions containing antigens or polynucleotides encoding antigens of the invention provide effectively targeted vaccines for prevention and treatment of HSV infection.